Read the latest news and updates from NCATS.

Is this email not displaying correctly?
View it in your browser.

National Center for Advancing Translational Sciences | Catalyzing Innovation
Volume 05 • Issue 07 • July 28, 2016

Director's Message

NCATS Director Dr. Chris Austin

Engaging patients at all stages of translation is crucial: Their input and perspectives as members of the research team help provide insights, focus, urgency and connectivity that can be instrumental in making the development, testing and deployment of...


Connect with NCATS


Top Story

The Murray family poses for a family photo in the park.

NCATS Videos Showcase Rare Disease Patients

There are more than 6,500 rare diseases, and there are treatments for only a few hundred of them. NCATS recently released a new video series to help raise awareness of both the challenges rare diseases patients and their families face and the hope offered through collaborative research. View the videos >

Facebook logo
Twitter logo

Ying Liang, M.D., Ph.D., University of Kentucky assistant professor of toxicology and cancer biology.

CTSA Program Scholar Awarded Prestigious NIH Grant

Clinical and Translational Science Awards (CTSA) Program scholar Ying Liang, M.D., Ph.D., received her first NIH Research Project Grant to investigate the role of a protein called latexin in preventing stem cell damage from cancer therapy. Liang credits NCATS’ CTSA Program training support as being instrumental in her success. Read more >

Facebook logo
Twitter logo

The interior of a specialized white blood cell, or macrophage, is depicted with a number of spherical lysosomes. (National Human Genome Research Institute Photo/Darryl Leja)

NIH Team Identifies Possible Treatment for Gaucher, Parkinson’s

A team of NIH scientists has identified and tested a molecule that shows promise as a possible treatment for Gaucher and Parkinson’s diseases. NCATS researchers included Juan Marugan, Omid Motabar, Wendy Lea, Wei Zheng, Noel Southall, Xin Xu, Bill Leister, Samarjit Patnaik, Wenwei Huang, Sam Michael, Paul Shinn, Danielle Van Leer and Marc Ferrer. Read more >

Facebook logo
Twitter logo

Representatives from NCATS and the Global Foundation for Peroxisomal Disorders pose in front of NCATS’ high-throughput screening robot.

Rare Disease Foundation Members Visit NCATS Labs

Global Foundation for Peroxisomal Disorders (GFPD) staff and volunteers visited NCATS laboratories in June to meet with Jim Inglese, Ph.D., director of NCATS’ Assay Development and Screening Technology laboratory, and his team. Peroxisomal disorders are metabolic diseases that cause neurological dysfunction. The GFPD is funding a postdoctoral fellow at NCATS to pursue small-molecule screening of peroxisome targets.

Twitter logo

Portraits of Dr. Marugan and Mr. Coy

Meet More NCATS Staff

Juan J. Marugan, Ph.D., is a chemistry team leader in NCATS’ Division of Pre-Clinical Innovation. George J. Coy heads NCATS’ Office of Financial Management and Budget. Learn more about these and other NCATS staff members via NCATS Staff Profiles >

Facebook logo
Twitter logo

Scientists drawing a chemical structure.

Research Opportunities and Announcements Highlights

More From NCATS

NCATS in the News


like us on Facebook |  follow us on Twitter |  forward to a friend |  watch us on YouTube

National Center for Advancing Translational Sciences
National Institutes of Health
6701 Democracy Boulevard, 9th Floor
Bethesda, MD 20892

For language access assistance, contact
the NCATS Public Information Officer.

Add us to your address book | Unsubscribe
NIH, National Center for Advancing Translational Sciences